Beyond the Single Click-Out: Snapchat Opens the Door to Branded Rx

For years, pharmaceutical marketers have faced a challenge on Snapchat: balancing engaging branded content with the disclosure requirements necessary for compliant Rx advertising. That may be changing.

In a new POV, Ali Hudson, Media Director, Paid Social, and Juniper Valeo, Director, Social Media, explore Snapchat’s newly announced multi-CTA attachments product, which allows brands to pair a primary call to action with multiple disclaimer links within a single ad unit. This enhancement addresses a long-standing structural limitation and creates new opportunities for branded pharmaceutical campaigns on the platform.

The implications extend beyond compliance. As younger audiences increasingly spend time on Snapchat, early adopters may have an opportunity to expand reach, test new engagement strategies, and strengthen their paid social mix. The POV outlines what marketers need to know now, including key considerations for piloting campaigns, adapting creative assets and evaluating Snapchat’s role in future channel plans.

For additional perspective, read the accompanying Med Ad News article and download the full POV for practical guidance on navigating this evolving opportunity.